ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Stock price data as of 01/18/2019
Closing price: 337.42
Support price level: $335.06
Resistance price level: N/A
Relative strength index (14-day RSI) 85.2
Beta 1.28
  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 33.9%.

  • Volatility is forecast to fall over the next month.

  • BIIB is above its 200-day moving average, providing a measure of support for long positions.

  • With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$257.52 $383.83 67.7%
200 day 50 day 20 day 10 day
$316.14 $317.70 $313.95 $331.36
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
34.9% 46.4% 33.9% 35.0%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 9.2% in the next week.

  • 19.8% in the next month.

  • 59.4% in the next year.